Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors
Authors:
- Dae-Kee KimDKDae-Kee Kim
- Sun Hee JungSJSun Hee Jung
- Ho Soon LeeHLHo Soon Lee
- Purushottam M. DewangPDPurushottam M. Dewang
- 1 February 2009
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 44 (2) , 568-576
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Role of Transforming Growth Factor Beta in Human CancerJournal of Clinical Oncology, 2005
- Transforming growth factor‐β and Smad signalling in kidney diseasesNephrology, 2005
- Transforming Growth Factor-β, Cell Signaling and Cardiovascular DisordersCurrent Vascular Pharmacology, 2005
- TGF‐β signaling and the fibrotic responseThe FASEB Journal, 2004
- Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: Implications for antifibrotic therapyHepatology, 2002
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- TGF-β signalling from cell membrane to nucleus through SMAD proteinsNature, 1997
- Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosisBiochemical Pharmacology, 1997
- Transforming growth factor βs and wound healingThe International Journal of Biochemistry & Cell Biology, 1997
- The Effect of TGF-β on Keloid Fibroblast Proliferation and Collagen SynthesisPlastic and Reconstructive Surgery, 1996